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Antimicrobial resistance (AMR) is a worldwide problem with serious health and economic
repercussions. Since the 1940s, underuse, overuse, and misuse of antibiotics have
had a significant environmental downside. Large amounts of antibiotics not fully
metabolized after use in human and veterinary medicine, and other applications, are
annually released into the environment. The result has been the development and
dissemination of antibiotic-resistant bacteria due to many years of selective pressure.
Surveillance of AMR provides important information that helps in monitoring and
understanding how resistance mechanisms develop and disseminate within different
environments. Surveillance data is needed to inform clinical therapy decisions, to
guide policy proposals, and to assess the impact of action plans to fight AMR.
The Functional Genomics and Proteomics Unit, based at the University of Trás-os-
Montes and Alto Douro in Vila Real, Portugal, has recently completed 10 years of
research surveying AMR in bacteria, mainly commensal indicator bacteria such as
enterococci and Escherichia coli from the microbiota of different animals. Samples
from more than 75 different sources have been accessed, from humans to food-
producing animals, pets, and wild animals. The typical microbiological workflow involved
phenotypic studies followed by molecular approaches. Throughout the decade, 4,017
samples were collected and over 5,000 bacterial isolates obtained. High levels of AMR to
several antimicrobial classes have been reported, including to β-lactams, glycopeptides,
tetracyclines, aminoglycosides, sulphonamides, and quinolones. Multi-resistant strains,
some relevant to human and veterinary medicine like extended-spectrum β-lactamase-
producing E. coli and vancomycin-resistant enterococci, have been repeatedly isolated
even in non-synanthropic animal species. Of particular relevance are reports of AMR
bacteria in wildlife from natural reserves and endangered species. Future work awaits
as this threatening yet unsolved problem persists.
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Graphical Abstract | Summary diagram of the antimicrobial resistance surveillance work developed by the UTAD Functional Genomics and
Proteomics Unit.
INTRODUCTION
The early XX century witnessed the beginning of the modern
antibiotic era with the first true antibiotic treatment, an
asfernamina (Salvarsan) discovered by Paul Ehrlich that was
successfully used to treat Syphilis (Elsner, 1910; Aminov, 2010).
The reign of antibiotics in clinical practice is commonly
associated with the discovery of penicillin produced by the fungus
Penicillium notatum by Fleming (2001). However, the first wide
use of antibiotics was with a sulfanamide antibiotic powder
carried by Second World War solders with effectiveness against a
wide range of infections (Davenport, 2012). The use of antibiotics
to treat bacterial infections became one of the main scientific
accomplishments; leading many scientists to believe that the
threat of infectious diseases had ended (Jones, 1999). However,
this golden age has come to an end in recent decades as we
have become aware of the evolution of antibiotic resistance in
bacterial strains, particularly in pathogens developing resistance
to an extensive range of antibiotics (Davies and Davies, 2010).
Antibiotics are small secondary metabolites, either naturally
produced by microorganisms or chemically synthetized,
to mediate competition among bacterial populations and
communities (Allen et al., 2010; Cordero et al., 2012). Antibiotics
are commonly found in the environment in sub-inhibitory
concentrations diminishing the growth rate of competing
populations rather than killing them. Natural or synthetic
antibiotics can also act as signal molecules regulating expression
of a large number of transcripts in different bacteria. Moreover,
antimicrobial compounds might target self-regulation of
growth, virulence, sporulation, motility, mutagenesis, stress
response, phage induction, transformation, lateral gene transfer,
intrachromosomal recombination, or biofilm formation (Goh
et al., 2002; Yim et al., 2007; Baquero et al., 2013).
Currently, antibiotics available for consumption are produced
either by microbial fermentation, semi- or full synthetically
manufactured. Antibiotics cause bacterial death or inhibit
growth by different mechanisms of action: (a) disrupting
cell walls, e.g., β-lactam and glycopeptides; (b) targeting the
protein synthetic machinery, e.g., macrolides, chloramphenicol,
tetracycline, linezolid, and aminoglycosides; (c) affecting the
synthesis of nucleic acids, e.g., fluoroquinolones and rifampin;
(d) inhibiting metabolic pathways, e.g., sulphonamides and folic
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acid analogs; or (e) disrupting the membrane structure, e.g.,
polymyxins and daptomycin (Sengupta et al., 2013).
Antimicrobial resistance (AMR) contributes to the
homeostasis of microbial populations and communities by
modulating the effect of naturally produced antibiotics (Cordero
et al., 2012; Baquero et al., 2013). Human misuse of antibiotics
has unbalanced this natural genetic system of resistance
(Osterblad et al., 2001; Xi et al., 2009). In some developed
countries, livestock alone represent about 50–80% of antibiotics
consumption; crops, pets and aquaculture collectively account
for an estimated 5%, and human therapy the remainder (Cully,
2014). The use of antibiotics in human and veterinary medicine
exerts a major selective pressure leading to the emergence and
spread of resistance because about 30–90% of antibiotics used are
not metabolized and are discarded basically unchanged (Sarmah
et al., 2006). The period of time that an antibiotic takes to be
degraded after release into the environment might influence how
it spreads and accumulates. For instance, penicillins are easily
degraded, while fluoroquinolones and tetracyclines persist for
longer. Direct discharges from antibiotics industries into water
eﬄuents can be shockingly high, a reality in both developed
and developing countries (Li et al., 2009; Joakim Larsson, 2014).
Antibiotics are also released into the environment via agricultural
application of manure and sewage water as fertilizers, and leakage
from waste storage facilities (Sarmah et al., 2006; Le-Minh et al.,
2010; Barrett, 2012).
The high concentration of antibiotics used prophylactically
by humans might have led to contamination of human waste
streams and exerted selection pressure on commensal and
pathogenic bacteria. It is not surprising that non-metabolized
antibiotics, resistance genes and mobile genetic elements are
frequently detected in wastewaters and sewage treatment plants
(Pellegrini et al., 2011). Often these compounds are not
removed during sewage treatment to the extent that incidences
of resistance genes are used as indicators of human impact
on aquatic ecosystems (Zuccato et al., 2000; Araujo et al.,
2010). Although antibiotics might be considered simply as
chemical pollutants, genetic mobile elements are capable of self-
replication and can be transmitted horizontally even between
phylogenetically distant bacteria (Gillings and Stokes, 2012).
Consequently, increased concentration of antibiotics in the
environment raises the diversity and the abundance of resistance
genes.
The consequences of antibiotic pollution are being actively
examined, and there is an imperative need for novel strategies to
curtail the release of antibiotics and bacteria from human sources
(Baquero et al., 2013). Furthermore, the long-term consequences
of spreading antibiotics and resistance genes cannot be predicted
without quantitative analysis over suitable timescales (Chee-
Sanford et al., 2009). The spread of AMR into the environment
occurs not only through the contamination of natural resources
but also through the food chain and direct contact between
human and animals.
Currently, AMR has been reported for all antibiotic classes
used both in human or veterinary medicine. An association
between antibiotic use and clinical AMR proliferation has also
been described (Skurnik et al., 2006; Pallecchi et al., 2008). AMR
is now considered a major challenge requiring urgent action in
the present to prevent a worldwide catastrophe in the future.
Portugal boasts some of the most diverse fauna and flora
in Europe, and in relation to its size is considered one of the
25 biodiversity hotspots of the world (Pereira et al., 2004).
Its farming systems are also numerous and varied. However,
Portugal is at high risk of losing this diversity. With the mission
of long-term surveillance of AMR in bacteria from different
sources, the Functional Genomics and Proteomics Unit, based
at the University of Trás-os-Montes and Alto Douro (Vila
Real, Portugal), has recently completed a decade of unceasing
research. Over the years, we have investigated the resistomes of
several bacteria, mainly commensal indicator bacteria such as
enterococci and Escherichia coli sampled from the microbiota
of different animals or from other sources. Here, we present an
overview of the resistance profiles of these bacteria in relation to
where they were found.
AMR AS A PUBLIC HEALTH CONCERN
Antimicrobial resistance has become recognized as a major
clinical and public health problem (Gillings, 2013). Every year
about 25,000 patients perish in the European Union (EU) because
of hospital-acquired resistant bacterial infection (ECDC, 2011).
Likewise, in the United States of America (USA), infections
caused by antibiotic resistant bacteria are more common among
the population than cancer, with at least 2 million people
infected every year, at least 23,000 of whom die (CDC, 2013).
Besides the clinical consequences of AMR, there are also large
societal costs. The number of new antibiotics coming to the
market over the past three decades has dramatically declined
as several pharmaceutical companies stopped searching for
antibiotics in favor of other antimicrobial drugs (Spellberg et al.,
2004; Walsh, 2013). When antimicrobial drugs are discovered
and developed, it is imperative to understand and predict
how resistance mechanisms might evolve in order to find
a method to control dissemination (Walsh, 2013). Genome-
scale research may offer insight into unknown mechanisms of
AMR (Tenover, 2006; Rossolini and Thaller, 2010). This will
then inform decisions on appropriate policies, surveillance, and
control strategies. The ideal AMR surveillance system should
be able to track long-term antibiotic resistance trends, regularly
alert healthcare professionals to novel resistance profiles, identify
emerging resistance patterns, and create an easy-access database
for physicians and scientists (Jones, 1999). To avoid a crisis,
governments must recognize the importance of this valuable
resource and implement a wiser and more careful use of
antibiotics, raising everyone’s awareness of this issue.
Investigating the zoonotic AMR problem in its full complexity
requires the collection of many types of data. Identifying
the most efficient points at which intervention can control
AMR mainly depends on quality collaboration between all the
stakeholders involved (Wegener, 2012). The One Health concept
is a universal strategy for improving connections between
stakeholders in all aspects of health for humans, animals and the
environment. The aim is that the synergism achieved between
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interdisciplinary collaborations will push forward healthcare,
accelerate biomedical research breakthroughs, increase the
effectiveness of public health, extend scientific knowledge and
improve clinical care. When properly implemented, millions of
lives can be protected and saved in the near future (Pappaioanou
and Spencer, 2008). The One Health initiative is therefore an ideal
framework for addressing zoonotic transmission of AMR bacteria
by monitoring and managing agricultural activities, food safety
professionals, human and animal clinicians, environment and
wildlife experts, while maintaining a global vision of the problem.
RESISTOME
The antibiotic resistome defines the pool of genes that contribute
to an antibiotic resistance phenotype (D’Costa et al., 2006).
Bacterial populations have exquisite mechanisms to transfer
antibiotic resistance genes by horizontal transfer, mainly in
densely populated microbial ecosystems. The human gut, for
instance, offers ample opportunities for bacteria of different
provenance to share genetic material, including the many
antibiotic resistance genes harbored by gut microflora (van
Schaik, 2015).
Currently, there is urgent focus on the natural resistome.
A resistome database was set up in Liu and Pop (2009)
and contains information on about 20,000 genes reported
so far. Conclusions from several metagenomics approaches
are that those 20,000 genes are just a small portion of
all resistomes, since other genes with different purposes not
directly related to antibiotic resistance may be implicated
(Gillings, 2013). Recently, a new bioinformatics platform has
been developed, the comprehensive antibiotic research database
(CARD), which integrates molecular and sequence data allowing
a fast identification of putative antibiotic resistance genes in
newly annotated genome sequences (McArthur et al., 2013).
Environmental and human associated microbial communities
have been shown to harbor distinct resistomes, suggesting that
antibiotic resistance functions are mainly constrained by ecology
(Gibson et al., 2015). However, to date, studies investigating the
roles of antibiotics and AMR outside of the clinical environment
are scarce. To know more about resistome composition and the
dynamics among AMR genes, new studies should be performed
on AMR communities in the environment.
AMR SURVEILLANCE IN INDICATOR
BACTERIA
Living organisms are defined by the genes they possess, while the
control of expression of this gene set, both temporally and in
response to the environment, determines whether an organism
can survive changing conditions and compete for the resources
it needs to reproduce. Changes to a bacterial genome are likely
to threaten the microbe’s ability to survive, but acquisition of
new genes may enhance its chances of thriving by allowing
growth in a formerly hostile environment. If a pathogenic
bacteria gains resistance genes it is more likely to survive in
the presence of antimicrobials that would otherwise eradicate
it, thus compromising clinical treatments. Bacterial genomes are
dynamic entities evolving through several processes, including
intrachromosome genetic rearrangements, gene duplication,
gene loss and gene gain by lateral gene transfer, and several
other chemical and genetic factors can trigger changes by locally
altering nucleotide sequences (Lawrence, 2005). AMR strains
emerge and spread as a combined result of intensive antibiotics
use and bacterial genetic transfer, and the incidences of resistant
bacteria from diverse habitats have been increasing (Coque et al.,
2008).
Recently, several pathogens have been reported as being
multidrug-resistant (MDR) and believed to be ‘unbeatable’
(Grundmann et al., 2006). Incidences of MDR strains of
Staphylococcus aureus, E. coli, Salmonella, and Enterococcus are
of international concern and have been reported thoroughly
by global health organizations (ECDC, 2013; WHO, 2014).
Methicillin-resistant Staphylococcus aureus (MRSA) is one of
the main causes of AMR associated clinical infections. Resistant
isolates are still being reported at a high rate, as in Portugal
where MRSA is recovered from more than 50% of isolates from
humans (ECDC, 2013). In 2011, the percentage of E. coli isolates
resistant to third-generation cephalosporins, through production
of extended-spectrum beta-lactamases (ESBLs), ranged from 3 to
36% in Europe. Over the last 4 years, MDR in E. coli has been
reported to be on the increase (ECDC, 2013). Also on European
territory, enterococci resistant to high-level aminoglycosides
(25–50% of recovered isolates) and vancomycin (VRE) (less than
5% of isolates) have been reported with some countries noting
an increase (ECDC, 2013). Salmonella are considered potential
sources of zoonosis. MDR Salmonella strains are often recovered
from human and animal isolates in Europe, with high incidence
in children (ECDC, 2013).
Human and animal commensal gastrointestinal bacteria are
continuously subject to diverse antimicrobial pressures (Levy
and Marshall, 2004). Resistant strains may act as reservoirs
of resistance genes that can easily be spread to pathogenic
strains (Allen et al., 2013). The potential pathogens E. coli
and enterococci are commonly used as indicators of the
selection pressure and AMR evolution through the environment
(Radhouani et al., 2014).
Escherichia coli are facultative anaerobic Gram-negative
bacteria belonging to the Enterobacteriaceae family. As a
commensal bacterium E. coli colonizes the gastrointestinal tract
of humans and animals, but it is found ubiquitously in soil, plants,
vegetables and water (van den Bogaard and Stobberingh, 2000).
E. coli is a potential pathogen and the leading cause of human
urinary tract infection, bacteraemia and gastroenteritis, among
many other infections that require therapeutic intervention (Fluit
et al., 2001; Kaper et al., 2004). E. coli has an outstanding capacity
to acquire and transfer antibiotic resistance genes from or to
other bacteria, which can later be disseminated from humans
to animals and to the natural environment, and vice versa
(Teuber, 1999). AMR E. coli strains, particularly those resistant
to important antibiotics, have been increasing (Collignon, 2009).
Likewise, Enterococcus are commensal bacteria from the
intestinal flora of humans and animals, and are frequently
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monitored as indicators of fecal contamination of food
products (Teuber and Perreten, 2000; Ramos et al., 2012).
Enterococci are facultative anaerobes capable of persisting in
extreme conditions caused by temperature and pH variations,
dehydration, and oxidative stress. In the last two decades they
have become dangerous nosocomial pathogens, persisting in
hospital environments where selective pressure from the presence
of antibiotics improves their resistome (Franz et al., 2011; Arias
and Murray, 2012). Enterococci can cause urinary tract, wound
and intra-abdominal infections, endocarditis, and bacteraemia.
Enterococcus faecalis and Enterococcus faecium are the major
species responsible for enterococci infections. Enterococci
are intrinsically resistant to some antibiotics (β-lactams and
aminoglycosides) and some species have specific AMR, such
as E. faecalis to lincosamides and streptogramins A, and
Enterococcus gallinarum and E. casseliflavus to vancomycin. They
can also easily exchange resistance genes with other bacteria.
Use of avoparcin, a glycopeptide antibiotic chemically similar to
vancomycin, as an animal feed additive in Europe, and of high
amounts of vancomycin in USA hospitals has led to the spread
of VRE in animals, humans, food, and the environment (Kirst
et al., 1998; Wegener, 1998). However, banning avoparcin in
2006 has not been sufficient to eradicate the AMR mechanisms
present in bacteria and some VRE still persist in animals and the
environment (Poeta et al., 2007b; Araujo et al., 2010; Ramos et al.,
2012).
COMPILATION OF UTAD AMR
SURVEILLANCE DATA
Antibiotic prescribing practices in the EU differ widely, and the
introduction of standardization would be one way to monitor
use more closely and possibly reduce the emergence of resistant
bacteria. The antimicrobials market has been increasing with
an average annual growth of 6.6% between 2005 and 2011.
Worldwide demand for antibiotics is conjectured to reach about
€34.1 billion in 2016. Currently, the market is dominated by
aminoglycosides, which account for 79% of demand, while
penicillins account for 8%, erythromycin 7%, tetracyclines 4%,
and chloramphenicol 1%. Market expansion is expected to slow
down to 4.6% in coming years (GR & DS, 2012). Between 2000
and 2010, consumption of antibiotic drugs increased by 36%
(from 54 billion standard units to 73 billion standard units).
The greatest increase was in low- and middle-income countries,
but in general, high-income countries still use more antibiotics
per capita (Van Boeckel et al., 2014). Portugal is in the top 10
European countries with the greatest consumption of antibiotics,
at around 21–25 doses per 1,000 habitants each year (Hede, 2014).
Nonetheless, exposure to antibiotics it is not only of antibiotic
consumption through prescribed human treatments but also by
their use in animal production. The antibiotic environmental
contamination can contribute further to the increased emergence
of resistance in pathogenic and environmental bacteria. The
antibiotics used in animal production may be excreted directly
into the environment, or accumulate in manure which could
later be spread on land as fertilizer (Almeida et al., 2014). The
global total consumption of antibiotics in livestock was estimated
in 2010 to be around 63,151 tons and it is project to rise 67%
by 2030. Increase driven by the growth in consumer demand
for livestock products in middle-income countries and a shift to
large-scale farms where antimicrobials are used routinely (Van
Boeckel et al., 2014).
The Portuguese annual amount of antibiotics used in human
and animal consumption was discussed in a report with data from
2010 to 2011. A first comparison of the antibiotic usage in human
and veterinary medicine in Portugal indicates that two-thirds of
the consumed antibiotics are used in veterinary medicine whereas
the rest one-third in human medicine. For human medicine
antibiotic prescription increased 4.5 tons (81.4–85.9 tons). In
these two registered years, the annual amount of the different
antibiotic groups was markedly larger for penicillins, which alone
accounted for more than 65.0%, followed by quinolones (13.0%),
macrolides (7.0%), cephalosporins (6.0%), and sulfonamides
(5.0%). In veterinary medicine the annual amount of antibiotics
sold was 179 tons in 2010 and 163 tons in 2011. Tetracyclines and
penicillins were the most sold therapeutic solutions for the both
years (Almeida et al., 2014).
Although it has been registered a decrease in the use of
antibiotics in Portugal, their consumption and use is still high.
Surveying AMR trends among bacteria is necessary to inform risk
analyses and guide public policy. Over one decade at University
of Trás-os-Montes and Alto Douro (UTAD), the antimicrobial
profiles of indicator bacteria E. coli (Table 1) and enterococci
(Table 2) have been studied in samples isolated from more than
75 different sources in Portugal. Figure 1 summarizes the data
according to the four groups of sources from which samples
were collected: humans, pets, food-producing animals, and wild
animals.
The fecal samples used in all studies, either from Human
or animal origin, were obtained following similar guidelines.
The fecal samples (one per animal) were recovered from
patients (in the case of human studies) and directly from the
intestinal tract in the animal studies. Samples were transported
in Cary-Blair medium from the place of recovery to the
Centre of Studies of Animal and Veterinary Sciences (CECAV)
facilities for processing. For E. coli selection, fecal samples
were seeded onto Levine agar plates and incubated for 24 h at
37◦C. One colony per sample with typical E. coli morphology
was selected and identified by classical biochemical methods
(Gram-staining, catalase, oxidase, indol, Methyl-Red, Voges-
Proskauer, citrate, urease, and triple sugar iron), and by the API
20E system (BioMerieux, La Balme Les Grottes, France). As
for the enterococcal isolation, fecal samples were sampled onto
Slanetz-Bartley agar plates and incubated at 37◦C for 24 h. One
colony with typical enterococcal morphology were identified
to the genus level by cultural characteristics, Gram staining,
catalase test, and bile-aesculin reaction. Antibiotic susceptibility
tests were made by the disk diffusion method following CLSI
recommendations. 16 antibiotics were tested against E. coli
isolates: ampicillin (10 mg), amoxicillin + clavulanic acid
(20 mg + 10 mg), cefoxitin (30 mg), cefotaxime (30 mg),
ceftazidime (30 mg), aztreonam (30 mg), imipenem (10 mg),
gentamicin (10 mg), amikacin (30 mg), tobramycin (10 mg),
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TABLE 1 | Description of all sources of Escherichia coli isolates analyzed in a decade of antimicrobial resistance (AMR) surveillance in Portugal by the
UTAD Functional Genomics and Proteomics Unit.
Sampling group Sample source Recovered samples
(n = 1,841
Recovered isolates
(n = 1,275)
Reference
Pets Dogs and cats 75 144 Costa et al., 2008
Humans Children 118 92 Barreto et al., 2009
Oral hygiene patients 46 2 Poeta et al., 2009
Food-producing animals Pigs, cattle, and sheep 198 192 Ramos et al., 2012
Wild animals Diarrheic rabbits 52 52 Poeta et al., 2010
Wild rabbits 77 44 Silva et al., 2010
Buzzards 42 36 Radhouani et al., 2012
Red foxes 52 22 Radhouani et al., 2013
Several wild animals 72 56 Costa et al., 2006
Seagulls 53 53 Radhouani et al., 2009
Lusitano horses 90 71 Moura et al., 2010
Iberian wolf 237 195 Goncalves et al., 2013a
Iberian lynx 27 18 Goncalves et al., 2012
Iberian lynx 98 96 Goncalves et al., 2013b
Echinoderms 250 10 Marinho et al., 2013
Wild birds 218 115 Santos et al., 2013
Wild rabbits 136 77 Silva et al., 2010
TABLE 2 | Description of all sources of Enterococcus spp. isolates analyzed in a decade of AMR surveillance in Portugal by the UTAD Functional
Genomics and Proteomics Unit.
Sampling group Sample source Recovered samples
(n = 2,730)
Recovered isolates
(n = 2,287)
Reference
Pets Dogs and cats 104 104 Rodrigues et al., 2001
Dogs and cats 220 142 Poeta et al., 2005a
Humans Humans 220 146 Poeta et al., 2005a
Children 118 101 Barreto et al., 2009
Oral hygiene patients 46 8 Poeta et al., 2009
Food-producing animals Poultry 220 152 Poeta et al., 2005a
Pigs, cattle, and sheep 198 194 Ramos et al., 2012
Wild animals Wild animals 77 140 Poeta et al., 2005b
Wild boars 67 134 Poeta et al., 2007b; Silva et al., 2010
Wild rabbit 77 64 Silva et al., 2010
Gilthead seabream 118 73 Barros et al., 2011
Seagulls 57 54 Radhouani et al., 2011
Buzzards 42 31 Radhouani et al., 2012
Iberian wolf 237 227 Goncalves et al., 2013a
Iberian lynx 30 27 Goncalves et al., 2011
Iberian lynx 98 96 Goncalves et al., 2013b
Echinoderms 250 144 Marinho et al., 2013
Lusitano horses 90 71 Moura et al., 2010
Red foxes 52 50 Radhouani et al., 2013; Santos et al., 2013
Wild birds 218 138 Santos et al., 2013
streptomycin (10 mg), nalidixic acid (30 mg), ciprofloxacin
(5 mg), sulfamethoxazole-trimethoprim (1.25 mg + 23.75 mg),
tetracycline (30 mg), and chloramphenicol (30 mg). The
identification of phylogenetic groups was performed as described
by Clermont E. coli phylo-typing method (Clermont et al.,
2000). In the case of enterococci, the isolates were tested for 11
antibiotics: [vancomycin (30 µg), teicoplanin (30 µg), Ampicillin
(10 µg), streptomycin (300 µg), gentamicin (120 µg), kanamycin
(120 µg), chloramphenicol (30 µg), tetracycline (30 µg),
erythromycin (15 µg), quinupristin-dalfopristin (15 µg), and
ciprofloxacin (5 µg)], also by the disk diffusion method. Species
identification was confirmed by polymerase chain reaction (PCR)
using primers and conditions for the different enterococcal
species. E. coli and enterococci isolates with resistance to one
or more antibiotics were selected for the characterization of
antibiotic-resistance genes. Their DNA was extracted and tested
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FIGURE 1 | Geographical distribution in Portugal showing the sources of samples containing bacterial isolates. The number and provenance of samples
containing enterococci (orange) and Escherichia coli (blue) are shown. Both types of bacteria were frequently isolated from several samples from humans, pets,
food-producing animals, and wild animals.
by PCR with specific primers already published. E. coli resistant
isolates were screened for the following resistance genes: blaTEM
and blaSHV (in ampicillin-resistant isolates); tetA and tetB (in
tetracycline resistant isolates); aadA, aadA5, strA, and strB (in
streptomycin-resistant isolates); and sul1, sul2, and sul3 (in
sulfa-methoxazoletrimethoprim-resistant isolates). Also, the
presence of intI, intI2 and qacED + sul1 genes was analyzed
by PCR in all sulfamethoxazole-trimethoprim-resistant isolates.
On the other hand, enterococci resistant isolates were tested by
PCR for detection of the following resistance genes: erm(B) and
erm(C) (in erythromycin-resistant isolates), tet(M) and tet(L)
(in tetracycline-resistant isolates), aph(3′)-IIIA (in kanamycin-
resistant isolates), aac(6′)-aph(2′′) (in gentamicin-resistant
isolates), ant(6)-Ia (in streptomycin-resistant isolates), vat(D)
and vat(E) (in quinupristin/dalfopristin-resistant isolates), and
van(A) (in vancomycin-resistant isolates). Positive and negative
controls were used in all PCR reactions, from the strain collection
of the University of Trás-os-Montes and Alto Douro (Portugal).
In this collation of data, a total of 1,841 samples were collected
and screened for E. coli. The overall E. coli recovery rate was
69.26% (Table 1), but rates were different among the different
sampling groups, ranging from 96.97% in fecal samples from
food-producing animals down to 52.08% in fecal samples from
pets. These are higher percentages than the E. coli recovery rate
(51%) from humans, domestic and food-producing animal feces,
or sewage and surface water in the USA (Sayah et al., 2005).
A total of 2,539 samples were screened for enterococci, and a
total of 2,096 enterococci isolates were obtained giving a recovery
rate of 78.1% (Table 2). Rates of recovery from the four sampling
groups were similar (75.93% for pet fecal samples, 66% for human
samples, 82.78% for fecal samples from food-producing animals;
and 88.39% for fecal samples from wild animals). These rates are
very similar to previously reported rates (77%) of enterococci
recovery from human, animal and environmental samples in
several European countries (Kuhn et al., 2003).
Escherichia coli DATA DESCRIPTION
Phenotypic and genotypic studies were used to assess the
AMR profile of the isolates. Figures 2 and 3 summarize the
results of tests for antibiotic resistance and identification of
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FIGURE 2 | Percentage of phenotypic antibiotic resistance detected in enterococci and E. coli isolates from each of the four sampling groups.
The resistance profile of enterococci from food-producing animals is distinct from those of the other sampling groups, showing the highest resistance to tetracycline,
streptomycin, trimethoprim-sulfamethoxazole, and chloramphenicol. Enterococci from pets displayed the lowest resistance profile to all tested antibiotics. TET,
tetracycline; STR, streptomycin; GEN, gentamicin; NAL, nalidixic acid; CIP, ciproflaxin; SXT, trimethoprim-sulfamethoxazole; CHL, chloramphenicol; AMP, ampicillin.
FIGURE 3 | Percentage of antimicrobial resistance (AMR) genes detected in E. coli resistant isolates from all sources over a decade.
associated resistance genes in E. coli isolates, comparing the
four different sample groups described in Table 1. Resistance
to all the antibiotics tested was found among the samples.
Remarkably, E. coli from food-producing animals showed higher
rates of resistance to tetracycline, streptomycin, trimethoprim-
sulfamethoxazole, and chloramphenicol than E. coli from
humans (Figure 2). Indeed fecal E. coli isolates recovered from
food-producing animals all across Europe have shown a high
prevalence of resistance to these antimicrobial agents (Guerra
et al., 2003; Enne et al., 2008; Lapierre et al., 2008). Despite
the ban on chloramphenicol use in farming in Europe since
1994, food-producing animals still carry resistant strains. Regular
and multipurpose use of antibiotics, dissemination of resistant
bacteria via fecal contamination and intensive animal production
have turned husbandry facilities into important reservoirs of
AMR bacteria (van den Bogaard and Stobberingh, 2000). High
levels of resistance to tetracycline and streptomycin have been
found in bacteria from wild animals. The high prevalence of
tetracycline resistance in either E. coli or enterococci found in
different wild animal species might be related to the recurrent
use of this antibiotic in veterinary medicine. The same may be
true of the prevalence of resistance to erythromycin, ampicillin,
aminoglycosides, and quinolones. One of the main routes of
transmission of resistant strains and resistant genes has been
shown to be through the food chain (Aarestrup et al., 2008).
Antibiotics can be administered to animals to treat (therapy)
or prevent (prophylaxis or metaphylaxis) illness and in the past
were also used to promote animal growth. Several classes of
antimicrobial agents are frequently used in veterinary medicine.
A 2013 report showed that in 2011 in 25 countries from the
EU/European Economic Area, tetracyclines (37%) were the most
sold antimicrobial class for administering to food-producing
species, followed by penicillins (23%), sulfonamides (11%),
macrolides (8%), lincosamides (2.9%), aminoglycosides (2%),
trimethoprim (1.6%), and fluoroquinolones (1.6%) (European
Medicines Agency, 2013). Antimicrobial use in veterinary
medicine and AMR in commensal E. coli from various food-
producing animals has indeed been correlated (Chantziaras et al.,
2014). Ampicillin is a β-lactam used as a farm animal growth
promoter (Sayah et al., 2005). E. coli from human samples
differ from E. coli from other sampling groups in terms of
their ampicillin resistance, which is of particular importance
considering that ampicillin is a first-line antibiotic commonly
effective against a broad spectrum of pathogens.
Comparing AMR E. coli from independent sources, several
genes conferring AMR were found in resistant isolates (Figure 3).
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FIGURE 4 | Number of ESBL-producing E. coli and resistance genes present in all isolates from different groups. blaCTX-M15 was the most frequent
ESBL gene recovered from E. coli, followed by blaCTX-M-1 and blaTEM-52. Otherwise, blaTEM-20, blaOXA-30, and blaCTX-M-9 genes were found in a few
ESBL-producing E. coli.
Fourteen different tet genes have been reported in Gram-negative
bacteria, encoding proteins active in the three mechanisms
of tetracycline resistance, namely an eﬄux pump, ribosomal
protection, or direct enzymatic inactivation of the antibiotic.
The resistance genes tetA and tetB confer resistance to
tetracycline, and were found at similar frequencies in all
different sources of resistant E. coli. However, tetA and tetB
are more likely to be associated with tetracycline resistance in
E. coli isolated from human and animal samples (Bryan et al.,
2004).
The streptomycin resistance genes aadA, strA, strB, and
aadA1 were found, in descending order of frequency, in resistant
E. coli. The strA and strB genes encode streptomycin-inactivating
enzymes which confer streptomycin resistance in many Gram-
negative bacteria distributed worldwide. The aadA gene encodes
an adenylylation enzyme that modifies streptomycin and, in the
aadA1 gene cassette, is often found in streptomycin-resistant
E. coli strains from human, animal, and food samples (Saenz et al.,
2004).
Gentamicin resistance genes aac(3)-II and aac(3)-IV
were present in resistant E. coli isolates. Trimethoprim-
sulfamethoxazole-resistant E. coli isolates had sul1, sul2 and/or
sul3 genes, and the integrons intI1 and intI2 genes, encoding
class 1 and class 2 integrases, respectively. The sul1, sul2, and
sul3 genes each encode dihydropteroate synthases to confer
plasmid-mediated resistance to sulphonamides (Perreten and
Boerlin, 2003; Skold, 2010). The sul1 gene is frequently found
linked to other resistance genes in class 1 integrons, while sul2 is
normally located on small plasmids of the incQ incompatibility
group, or other small plasmids represented by pBP1 (Skold,
2010). The sul1 and sul2 genes have been regularly found
at similar frequencies among sulphonamide resistant Gram-
negative clinical isolates. However, an increase in prevalence
of the sul2 gene has been observed. The association between
sul2 and multiresistance plasmids, which may be co-selected
through the use of other antimicrobial agents, might explain
the increased prevalence (Blahna et al., 2006; Frank et al.,
2007).
Chloramphenicol resistant E. coli isolates have the resistance
genes cmlA and floR, both coding eﬄux pumps that reduce the
intracellular concentration of antibiotics by exporting different
FIGURE 5 | Percentages of enterococci species isolated from
samples. Enterococcus faecium is the most frequently isolated enterococci
species among all recovered samples and Enterococcus gallinarum the least.
molecules (Saenz et al., 2004). Some infections are difficult to
treat because of bacterial expression of multidrug eﬄux systems
causing resistance. ESBLs confer resistance to penicillins and
most cephalosporins, including third-generation cephalosporins,
and more than 700 different ESBLs have now been described
(van Duijn et al., 2011). A total of 403 isolates of ESBL-
producing E. coli were obtained from all four sampling groups:
humans (n = 138), pets (n = 8), food-producing animals
(n = 116), and wild animals (n = 141). Figure 4 shows all
genes encoding ESBLs that were detected in these isolates. The
most prevalent ESBL genes were blaCTX−M−1 (n = 94) and
blaTEM−52 (n = 85), specifically isolated from E. coli from
food-producing and wild animals, followed by the blaCTX−M−32
(n = 57) gene found in isolates from human samples. The
mechanisms of resistance against one antibiotic might not
be exclusive, and activity may be exhibited against other
similar compounds. For instance, it has been proven that
mutations in the genes encoding penicillin-inactivating enzymes
(e.g., TEM and SHV) can also confer resistance to third-
generation cephalosporins or β-lactamase inhibitors (Martinez
et al., 2007).
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ENTEROCOCCI DATA DESCRIPTION
Several species of enterococci were recovered from different
environments, with some being more common than others
depending on the source of the sample. Figure 5 summarizes
all data on enterococci species prevalence reported in the
publications listed in Table 2. E. faecalis is the most common
enterococcal species in human stools and the most frequent
cause of clinical infection. The natural resistance of this
species to penicillin, cephalosporins, and quinolones has
contributed to its emergence as a cause of nosocomial
infection. However, E. faecium is inherently more antibiotic-
resistant and has also gradually become a major hospital
pathogen (French, 2010; Radimersky et al., 2010). Overall
from all the enterococci species we isolated, E. faecium was
by far the most frequently recovered (52.9%), followed by
E. faecalis, E. hirae, E. durans, E. casseliflavus, and E. gallinarum
(Figure 5).
Figures 6 and 7 show the collated antibiotic resistance
data of enterococci isolates from the different sources listed
in Table 2. Remarkably, more enterococci from the group
of food-producing animals were resistant to tetracycline and
erythromycin than from the human group (Figure 6). Many
enterococci resistant to tetracycline and erythromycin were
also found in the wild animals group. Enterococci resistant to
kanamycin and chloramphenicol were more frequent in samples
from humans than from other sources.
The distribution of AMR genes in the different sampling
groups is illustrated in Figure 7. The tetM and tetL genes
are associated with the tetracycline-resistance phenotype in
enterococci. Tetracycline resistance due to TetL eﬄux proteins
has been becoming more frequently reported among Gram-
positive bacteria from animal sources (Figueiredo et al., 2009;
Radhouani et al., 2010).
Erythromycin-resistance in enterococci is usually associated
with the presence of the ermB gene. The ermB and tetM genes
have been frequently identified together in the same isolate,
probably because of they both occur in the mobile conjugative
transposon Tn1545, prevalent in clinically important Gram-
positive bacteria (De Leener et al., 2004). The resistance genes
ant(6)-Ia, aac(6′)-aph(2′), aph(3′)-IIIA and catA were present
in enterococci isolates resistant to streptomycin, gentamicin,
FIGURE 6 | Percentage of phenotypic antibiotic resistance detected in Enterococcus spp. isolates from each of the four sampling groups. Enterococci
isolates showed high resistance levels to tetracycline and erythromycin, regardless of the source. However, food-producing animals and pets stand out from the
other sampling groups. Streptomycin, kanamycin, and chloramphenicol-resistant enterococci are more frequent in samples from humans than from other sources.
TET, tetracycline; ERY, erythromycin; STR, streptomycin; GEN, gentamicin, KAN, kanamycin; CHL, chloramphenicol.
FIGURE 7 | Percentage of AMR genes detected in resistant Enterococci isolates from all sources over a decade. Resistance genes tet(M)/tet(L), erm(B),
ant(6)-Ia, aac(6′)-aph(2′), aph(3′)-IIIA, and catA were present in enterococci isolates resistant to tetracycline, erythromycin, streptomycin, gentamicin, kanamycin, and
chloramphenicol, respectively. TET, tetracycline; ERY, erythromycin; STR, streptomycin; GEN, gentamicin; KAN, kanamycin, CHL, chloramphenicol.
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FIGURE 8 | Number of vancomycin-resistant enterococci species, and resistance genes present in all isolates from different groups. E. gallinarum and
E. casseliflavus are intrinsically resistant to vancomycin, and harbor the genes vanC1 and vanC2, respectively, in their genome.
kanamycin, and chloramphenicol, respectively. Resistance to
all tested antibiotics has been showed in isolates from all
groups.
The presence of VRE isolates was noted in all four groups
(Figure 8): humans (n = 21), pets (n = 5), food-producing
animals (n = 57), and wild animals (n = 107). The presence
of VRE isolates in diverse samples from Portugal is likely to be
related to the use of avoparcin to promote growth of food animals
in Europe since the 1970s until its prohibition in 2006. VRE was
first characterized in Uttley et al. (1988), and has been repeatedly
isolated since then from several sources. Many antimicrobials
used in food animals belong to the same classes as those used in
humans, leading to concerns about cross-resistance (Furuya and
Lowy, 2006). For instance, vancomycin is still the most widely
used antibiotic to treat serious infections like MRSA. Vancomycin
resistance has emerged in S. aureus through acquisition of the
vanA gene from VRE (Chang et al., 2003). It is important
therefore to highlight the higher number of vancomycin resistant
determinants found in wild animals compared to humans. In
Europe, spread from animals to humans appears to have occurred
outside hospital facilities, which explains why VRE is more
commonly found in the environment than in the community
(Furuya and Lowy, 2006).
CONCLUSION
Generalized use of antibiotics by humans is a recent addition
to the natural and ancient process of antibiotic production and
resistance evolution that still occurs on a global scale in the
soil (Woolhouse et al., 2015). The main attributed cause of
the rise and spread of AMR is the extensive clinical use of
antibiotics in both human and veterinary medicine (Levy, 2001).
However, antibiotic use in veterinary medicine alone does not
explain the spread and persistence of AMR bacteria in animal
populations in which the antibiotic use is discontinued or else
is very sporadic or limited like in wildlife. AMR does not have
borders, so it can freely cross through several populations, and
homologous resistance genes have been reported in bacteria
from pathogens, normal flora and soil. Farm animals are a
significant factor in this system and they are still exposed to
large amounts of antibiotics and act as reservoirs of many
resistance genes. Other risk factors such as antibiotic residues
in the environment and AMR gene dissemination in different
human and animal populations also have an impact on the AMR
levels (Alali et al., 2009). We are currently facing the potential
loss of antimicrobial therapy, so it is essential to continue tracking
AMR.
FUTURE PERSPECTIVES
Human use of antibiotics for medicine and agriculture may
have consequences far beyond their intended applications.
The environment is a major reservoir of resistant organisms
and antibiotic drugs freely circulating; though not much is
known about the antibiotic resistome, shading their hypothetical
impact on clinically important bacteria (Allen et al., 2010).
Several resistance genes have been reported in distinct bacterial
species, from diverse sources (Poeta et al., 2007a; Pallecchi
et al., 2008; Gillings and Stokes, 2012). Nonetheless, more
studies using standardized methods are required to recognize
roles and patterns of antibiotic resistance genes in microbial
communities. In the meantime, it is important to moderate the
use of antimicrobials and restrain the rise and dissemination
of AMR bacteria, so the management of emerging zoonotic
diseases and their impacts might be forecasted (Allen et al.,
2010). The foreseen decline in antibiotics effectiveness and the
current lack of new antimicrobials on the horizon to replace
those that become ineffective brings added urgency to the
protection of the efficacy of existing drugs (Carlet, 2012; WHO,
2014). Meanwhile, omics approaches to generate molecular data
on AMR mechanisms will continue to be the foundation of
our work at the Functional Genomics and Proteomics Unit at
UTAD.
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